ArticleJAAD international2024

Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2).

Gil Yosipovitch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.